NO20076662L - Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff - Google Patents

Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff

Info

Publication number
NO20076662L
NO20076662L NO20076662A NO20076662A NO20076662L NO 20076662 L NO20076662 L NO 20076662L NO 20076662 A NO20076662 A NO 20076662A NO 20076662 A NO20076662 A NO 20076662A NO 20076662 L NO20076662 L NO 20076662L
Authority
NO
Norway
Prior art keywords
therapeutic antibody
malantigen
absence
independent
detection
Prior art date
Application number
NO20076662A
Other languages
English (en)
Norwegian (no)
Inventor
Helmut Lenz
Werner Scheuer
Martina Thier
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20076662L publication Critical patent/NO20076662L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20076662A 2005-07-06 2007-12-28 Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff NO20076662L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05014618 2005-07-06
EP06004447 2006-03-06
PCT/EP2006/006524 WO2007003420A1 (en) 2005-07-06 2006-07-05 Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody

Publications (1)

Publication Number Publication Date
NO20076662L true NO20076662L (no) 2008-04-03

Family

ID=36922121

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076662A NO20076662L (no) 2005-07-06 2007-12-28 Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff

Country Status (19)

Country Link
US (1) US20070009976A1 (https=)
EP (2) EP1902315A1 (https=)
JP (1) JP2008545145A (https=)
KR (1) KR20080016939A (https=)
AR (1) AR053948A1 (https=)
AU (1) AU2006265275A1 (https=)
BR (1) BRPI0612591A2 (https=)
CA (1) CA2613187A1 (https=)
CR (1) CR9635A (https=)
EC (1) ECSP088081A (https=)
IL (1) IL188317A0 (https=)
MA (1) MA29730B1 (https=)
MX (1) MX2008000277A (https=)
MY (1) MY157955A (https=)
NO (1) NO20076662L (https=)
NZ (1) NZ564471A (https=)
RU (1) RU2008103608A (https=)
TW (1) TWI312864B (https=)
WO (1) WO2007003420A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130056201A (ko) * 2000-05-19 2013-05-29 제넨테크, 인크. ＥｒｂＢ 길항제에 의한 암 치료요법에 대한 효과적인 반응의 가능성을 개선시키기 위한 유전자 검출 분석
KR20140032004A (ko) 2004-07-22 2014-03-13 제넨테크, 인크. Ｈｅｒ２ 항체 조성물
KR101134208B1 (ko) 2004-10-01 2012-04-09 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 촬상 장치 및 그 방법
JO3000B1 (ar) 2004-10-20 2016-09-05 Genentech Inc مركبات أجسام مضادة .
EP1850874B1 (en) 2005-02-23 2013-10-16 Genentech, Inc. Extending time to disease progression or survival in ovarian cancer patients using pertuzumab
PE20070207A1 (es) * 2005-07-22 2007-03-09 Genentech Inc Tratamiento combinado de los tumores que expresan el her
US8358354B2 (en) 2009-01-26 2013-01-22 The Board Of Trustees Of The Leland Stanford Junior University Correction of optical abberations
US8243157B2 (en) 2006-02-07 2012-08-14 The Board Of Trustees Of The Leland Stanford Junior University Correction of optical aberrations
MX2009008981A (es) 2007-03-02 2009-09-02 Genentech Inc Prediccion de respuesta a un inhibidor her.
TWI472339B (zh) 2008-01-30 2015-02-11 Genentech Inc 包含結合至ｈｅｒ２結構域ii之抗體及其酸性變異體的組合物
BRPI0812682A2 (pt) 2008-06-16 2010-06-22 Genentech Inc tratamento de cáncer de mama metastático
WO2013055874A2 (en) 2011-10-14 2013-04-18 Genentech, Inc. Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab
KR101327542B1 (ko) * 2012-03-15 2013-11-08 광주과학기술원 양자점 기반의 경쟁 면역분석법 및 다중 유세포 분석법을 이용한 시료 중 오염물질의 검출 방법
AU2012232949B2 (en) * 2012-09-28 2014-07-03 Willowtree Holdings Pty Ltd Temporary bulkhead
RU2019115089A (ru) 2013-04-16 2019-06-11 Дженентек, Инк. Варианты пертузумаба и их аналитическая характеристика
JP2017513901A (ja) 2014-04-25 2017-06-01 ジェネンテック， インコーポレイテッド トラスツズマブ−ｍｃｃ−ｄｍ１及びペルツズマブにより早期の乳癌を処置する方法
US11406715B2 (en) 2015-05-30 2022-08-09 Genentech, Inc. Methods of treating HER2-positive metastatic breast cancer
WO2017087280A1 (en) 2015-11-16 2017-05-26 Genentech, Inc. Methods of treating her2-positive cancer
AU2017387909A1 (en) 2016-12-28 2019-06-27 Genentech, Inc. Treatment of advanced HER2 expressing cancer
SG11201905622VA (en) 2017-01-17 2019-08-27 Genentech Inc Subcutaneous her2 antibody formulations
US11077189B2 (en) 2017-03-02 2021-08-03 Genentech Inc. Adjuvant treatment of HER2-positive breast cancer
EP3615695A1 (en) 2017-04-24 2020-03-04 Genentech, Inc. Erbb2/her2 mutations in the transmebrane or juxtamembrane domain
AU2020456731A1 (en) 2020-06-29 2023-01-05 F. Hoffmann-La Roche Ag Pertuzumab plus trastuzumab fixed dose combination

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2095818B (en) 1981-03-27 1985-10-02 Exxon Research Engineering Co Staged adsorption/resorption heat pump
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
EP1400536A1 (en) * 1991-06-14 2004-03-24 Genentech Inc. Method for making humanized antibodies
WO1993021319A1 (en) 1992-04-08 1993-10-28 Cetus Oncology Corporation HUMANIZED C-erbB-2 SPECIFIC ANTIBODIES
CN101412758A (zh) 1996-10-18 2009-04-22 基因技术股份有限公司 抗ErbB2抗体
US7718387B2 (en) * 2001-09-20 2010-05-18 Board Of Regents, The University Of Texas System Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
ES2392525T3 (es) * 2002-07-15 2012-12-11 F. Hoffmann-La Roche Ag Tratamiento del cáncer con el anticuerpo dirigido contra ErbB2 rhuMAb 2C4

Also Published As

Publication number Publication date
EP1902315A1 (en) 2008-03-26
AU2006265275A1 (en) 2007-01-11
TWI312864B (en) 2009-08-01
WO2007003420A1 (en) 2007-01-11
ECSP088081A (es) 2008-02-20
MA29730B1 (fr) 2008-09-01
EP2194380A3 (en) 2010-07-14
CA2613187A1 (en) 2007-01-11
IL188317A0 (en) 2008-04-13
KR20080016939A (ko) 2008-02-22
AR053948A1 (es) 2007-05-23
EP2194380A2 (en) 2010-06-09
CR9635A (es) 2008-02-20
TW200741203A (en) 2007-11-01
NZ564471A (en) 2010-04-30
MY157955A (en) 2016-08-30
US20070009976A1 (en) 2007-01-11
MX2008000277A (es) 2008-03-24
RU2008103608A (ru) 2009-08-20
BRPI0612591A2 (pt) 2010-11-23
JP2008545145A (ja) 2008-12-11

Similar Documents

Publication Publication Date Title
NO20076662L (no) Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff
MX2009013411A (es) Deteccion de antigenos transportados por eritrocitos y de anticuerpos anti-eritrocitos.
BRPI0519119A2 (pt) sistema colorimÉtrico e mÉtodo para detectar um analito
BRPI0809138B8 (pt) método para detectar a presença ou quantidade de um ou mais analitos em uma amostra biológica
WO2008070229A3 (en) Detection of pathogenic aggregates of protein in a sample by homologous elisa
NZ609824A (en) Immunochromatography devices, methods and kits
CA2844033C (en) Method for detecting pancreatic cancer
WO2013074520A3 (en) Detection, isolation and analysis of rare cells in biological fluids
NZ609363A (en) Methods for determining anti-drug antibody isotypes
BRPI0906060A2 (pt) anticorpos isolados, métodos de preparo de um anticorpo anti-clostridium difficile, composição e método para a detecção da presença de um esporo de clostridium difficile em uma amostra
WO2010096674A3 (en) A+ biomarker assays
WO2008073895A3 (en) Methods and devices for testing saliva
MX353566B (es) Metodos y sistemas para amplificacion de señal de bioensayos.
WO2006069023A3 (en) Assay method and apparatus with reduced sample matrix effects
EA201370030A1 (ru) Бифункциональный количественный анализ in vitro связывания мишени для обнаружения нейтрализующих антител к антителам-мишеням
WO2009111572A3 (en) Cell, method and kit for conducting an assay for neutralizing antibodies
SG164389A1 (en) Detection of a therapeutic antibody in an experimental animal
WO2011003598A3 (de) Detektion von antigenen
WO2007024735A3 (en) Method and antibodies for detecting nitrofuran
MX2008000282A (es) Anticuerpos monoclonales, lineas celulares de hibridomas, metodos y kits para la deteccion de fitasa.
GB201119585D0 (en) Assay
WO2009044561A1 (ja) 抗ｐｒｏＮＴ／ＮＭＮモノクローナル抗体
WO2006099537A3 (en) The use of antibody-surrogate antigen systems for detection of analytes
ATE533053T1 (de) Nicht-elispot-test
WO2012141792A3 (en) Adiponectin receptor c-terminal fragments (ctf)-immunoglobulin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application